Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LSD in Palliative Care
NCT05883540Phase 2Recruiting
- Sponsor
- University Hospital Basel
- Start
- Jun 2024
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Lysergide in anxiety disorder, major depressive disorder (MDD), pain, sponsored by University Hospital Basel. Started Jun 2024; status: recruiting.
02
Drugs
Lysergide
03
Conditions
anxiety disordermajor depressive disorder (MDD)pain
Beyond the preview
Go deeper on NCT05883540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05883540.